Navigation Links
High-efficiency Derivatives of the BL21 Series for Protein Expression


New BL21-Gold cells accelerate the protein expression process

Melody Jerpseth Bruce Jerpseth Lisa Breister Alan Greener
Stratagene

Stratagene has created variants of BL21 competent cells, the new BL21-Gold series. Epicurian Coli BL21-Gold * competent cells lack the EndA1 nuclease and offer 100-fold higher transformation efficiencies than the parental strains. These two features eliminate the process of first cloning and sequencing many protein expression constructs in an EndA strain and then retransforming the plasmids of interest into the BL21 strains for expression.

Epicurian Coli BL21 competent cells are the E. coli strains chosen for protein expression when a gene of interest is to be expressed from the T7 promoter.## These strains have been engineered either to contain an inducible T7 RNA polymerase gene or to readily allow one to be introduced by phage infection.1 BL21 competent cells contain a mutation in the ompT protease gene, which is implicated in the degradation of some recombinant proteins. BL21 cells are derivatives of E. coli B and naturally lack the Lon protease, which may affect the stability of some recombinant proteins.2

Although the BL21 cell series is engineered for protein expression, these strains have two significant problems that limit their use as primary transformation hosts. Because BL21 cells are derived from the E. coli B cell line rather than the E. coli K-12 cell line, their efficiency is relatively low (1 x 106 cfu/g of pUC18 DNA). The other problem causing BL21 competent cell lines to be inadequate for initial transformation experiments is that they contain the EndA gene, which encodes an endonuclease that rapidly degrades miniprep DNA. This degradation makes restriction
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Codon Bias-Adjusted BL21 Derivatives for Protein Expression
2. Analysis of Blood Serum on the Liberty Series II ICP-AES with the axially-viewed plasma
3. A New C-Terminal GST Vector for Protein Production in S. pombe
4. New Mammalian Two-Hybrid System Detects Protein-Protein Interactions
5. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
6. Simple, Sensitive, and Rapid Detection of FLAG -Tagged Fusion Proteins
7. New Yeast Cloning System for Producing Proteins with Native Amino Acid Sequences
8. Optimized Imaging of Protein Gels Stained with Coomassie Brilliant Blue Dye
9. High-Level Protein Expression, One-Column Purification, and FLAG Epitope Tagging in E. coli
10. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
11. Yeast Protein Production System Features High Yields and One-Step Purification
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: High efficiency Derivatives the Series for Protein Expression

(Date:3/2/2015)... PARK, Calif. , March 2, 2015  Asterias ... in the emerging field of regenerative medicine, today announced ... 2014 financial and operating results on Tuesday, March 10, ... The Company will host a conference call and webcast ... / 1:30 p.m. Pacific to discuss the results and ...
(Date:3/2/2015)... Boston, Massachusetts (PRWEB) March 02, 2015 ... legal services, today announced the addition of Debbie Casey ... group’s capabilities in the healthcare space. , ... industry, most of which with Fresenius Medical Care North ... will leverage her extensive experience to work with Outside ...
(Date:2/27/2015)... SUMMERLAND, British Columbia , Feb. 27, ... XON ), a leader in synthetic biology, today announced ... Specialty Fruits (OSF), the pioneering agricultural company behind ... first non-browning apple. Through the acquisition, Intrexon expands its ... more appetizing and convenient for consumers while providing economic ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Immunovaccine ... and immunotherapy company, today announced that the U.S. ... for Fast Track designation and Phase I clinical ... conjunction with the mutual co-development agreement signed with ... Fast Track designation for the DPX-Survivac. , “We ...
Breaking Biology Technology:Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2014 Results on March 10, 2015 2Outside GC Expands Healthcare Team 2Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3
... This release is available in Spanish . ... leading in Spain the European project within the VII Framework ... buildings which host large numbers of people, such as sports ... by the management and optimisation of energy in its three ...
... 5, 2011 Sangamo BioSciences, Inc. (Nasdaq: SGMO ... will provide an update on the progress of Sangamo,s ZFP ... strategy at 12:30 pm PT (3:30 pm ET) on Thursday, ... Conference which will be held in San Francisco. ...
... HOUSTON, Jan. 5, 2011 International energy pricing agency ... expansion into US and Canadian wood chip pricing complements ... broader European biomass indexation. " Argus understands ... to be at the forefront, providing transparency to emerging biomass ...
Cached Biology Technology:Tecnalia leads the integration of energy efficiency in sports facilities 2Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference 2Argus Launches North American Wood Chip Price Assessments 2
(Date:2/23/2015)... 23, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... 62114357 for DISTRIBUTED VOICE DIRECTED PAYMENT METHOD ... a new groundbreaking payment method. Payment accounts may be ... only be accessed if both the speech (the word ...
(Date:2/18/2015)... 2015  Cepheid (NASDAQ: CPHD ) today announced ... and invited investors to participate via webcast. , Cowen ... Tuesday, March 3, 2015 at 11.20 a.m. Eastern Time ... FL Wednesday, March 4, 2015 at 10.25 a.m. ... live webcasts for these events, please visit Cepheid,s website at ...
(Date:2/12/2015)...   MedNet Solutions , a global life ... systems, has recently bolstered its iMedNet™ ... iMedNet as the eClinical solution of ... consultants.  Building on the Program,s existing benefits (including ... co-marketing opportunities), MedNet,s new and improved program provides ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3Cepheid to Webcast Upcoming Financial Presentations 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
... intimately familiar with the awe-inspiring photos of space shuttle launches ... But how many people have paused for even a second ... a two-week space shuttle mission or are living for months ... book The Astronaut,s Cookbook Tales, Recipes, and More ...
... 13 BIO-key International, Inc. (OTC Bulletin Board: BKYI), ... identification solutions, today reported results for the third quarter ... The Company,s results reflected operating profitability for each quarter ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ) , As a result of ...
... DALLAS Nov. 12, 2009 UT Southwestern ... to date for basic and patient-oriented research from the ... billion stimulus package President Barack Obama signed into law ... the National Science Foundation (NSF) and the National Institutes ...
Cached Biology News:The astronaut's cookbook 2BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability 2BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability 3BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability 4BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability 5BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability 6UT Southwestern receives $42 million in Recovery Act stimulus funding 2UT Southwestern receives $42 million in Recovery Act stimulus funding 3
MAb to HSV-2, gG-2 HSV-2 Glycoprotein G-2...
Immunogen for A300-655A was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 5 of the C-terminal repeat YSPTSPS....
human Exodus-2 Research Focus: cytokine/growth factor Storage Temperature: -20C Shipping Temperature: 4C...
MAb to IgG2 (Fc gamma-2) IgG2 (Fc, gamma-2 epitope)...
Biology Products: